HIV Drug Candidate Study

Awarded Award Notice Posted

Solicitation number
NICHD2017028
Agency
National Institutes of Health Department of Health and Human Services
Awarded
to Bioqual, Inc.
Set-aside
No set-aside

Opportunity facts

Contract number
HHSN275201700725P Federal contract award
NAICS code
541711 Research and Development in Biotechnology
PSC
Not on record

Notice details come from SAM.gov. Updated .

Notice text

Added: Jun 27, 2017 1:38 pm This Small Business Sources Sought Notice is for information and planning purposes only and shall not be construed as a solicitation or as an obligation or commitment by the Government. This notice is intended strictly for Market Research. The National Institutes of Health (NIH) Eunice Kennedy Shriver, National Institute of Child Health and Human Development is conducting a market survey to determine the availability and technical capability of qualified small business, veteran-owned small business, service-disabled veteran-owned small business or HUBZone small businesses capable of HIV Drug Candidate Study.

The NIDDK has an ongoing project. Proposal will be to study the performance of a new drug that inactivates HIV and perform detailed mechanism-based studies in non-human primates (NHP) infected with SIV. This purchase of antiviral testing is a requirement that must be done by a uniquely qualified company to allow proper evaluation of efficacy and any toxicity in NHP. Lab-to-lab variability is inherent in biological testing, and is uniquely able to handle the drug, responsibly administer it to NHP, and track the effect on SIV.


The intended procurement will be classified under North American Industrial Classification (NAICS) code 541711 with a size standard of 1000. All respondents are requested to identify their firm's size and type of business. Interested firms responding to this market survey must provide (a) capability statement demonstrating their experience, skills and capability to fulfill the Government's requirements for the above. The capability statement shall be in sufficient enough detail, but not to exceed 15 pages, so that the Government can determine the experience and capability of your firm to provide the requirements above. Your capability statement, not to exceed 15 pages, should include references. Capability statement must be received at the email address identified in this synopsis by 11:00 A.M. local time on July 5, 2017. Any questions regarding this announcement must be sent via email to verne.griffin@.nih.gov and must include solicitation NICHD2017028 in the subject line of email.


This synopsis is for information and planning purposes and is not to be construed as a commitment by the Government, nor will the Government pay for information solicited. Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provided feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate response to a solicitation.


Disclaimer and Important Notes: This notice does not obligate the Government to award a contract or otherwise pay for the information provided in response. The Government reserves the right to use information provided by respondents for any purpose deemed necessary and legally appropriate. Any organization responding to this notice should ensure that its response is complete and sufficiently detailed to allow the Government to determine the organization's qualifications to perform the work. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provided feedback to respondents with respect to any information submitted. After a review of the responses received, a pre-solicitation synopsis and solicitation may be published in Federal Business Opportunities. However, responses to this notice will not be considered adequate response to a solicitation. Confidentiality - No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use any non-proprietary technical information in any resultant solicitation(s)." PLEASE NOTE: In order to receive an award, contractor must be registered and have valid certification in the System for Award Management (SAM) http://www.sam.gov

Notice history

Notices posted for this opportunity, newest first
Notice Type Posted
HIV Drug Candidate Study Latest Award Notice
HIV Drug Candidate Study This notice · Original Award Notice

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity